<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HB2462</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HB2462 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="number"></td><td class="junk"></td><td class="xsl"><table class="xsl" width="100%"><tr><td class="xsl"><center><b><pre><font size="3" face="Courier New">104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026</font><br>HB2462</pre></b></center><p> </p>Introduced 2/4/2025, by Rep. Maurice A. West, II<p> </p><b>SYNOPSIS AS INTRODUCED:</b><br> </td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><table class="xsl" width="100%"><colgroup width="50%"></colgroup><colgroup width="50%"></colgroup><tr><td class="synopsis"><code>410 ILCS 27/5</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>410 ILCS 27/10</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>410 ILCS 27/25 new</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>745 ILCS 49/66 new</code></td><td class="synopsis"></td></tr></table><p></p></td></tr><tr><td class="xsl"><code>    </code><code>Amends the Epinephrine Injector Act. Defines "authorized individual". </code><code>Adds references to "authorized individual" in provisions regarding those </code><code>persons who may provide or administer an epinephrine injector. Requires </code><code>the issuance of a certificate upon completion of an anaphylaxis training </code><code>program. Adds provisions regarding good Samaritan protections. Amends the </code><code>Good Samaritan Act. Limits the liability of authorized individuals who may </code><code>provide or administer an epinephrine injector.</code></td></tr><tr align="right" class="lineNum"><td class="xsl"><br><br></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left"></td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><p> </p><p> </p><center><b>A BILL FOR</b></center><p></p></td></tr></table><p> </p></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AN ACT concerning health.</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>The Epinephrine Injector Act is amended by </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>changing Sections 5 and 10 and by adding Section 25 as follows:</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 27/5)</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 5. </code><code>Definitions. </code><code>As used in this Act:</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Administer" means to directly apply an epinephrine </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>injector to the body of an individual.</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Authorized entity" means any entity or organization, </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>other than a school covered under Section 22-30 of the School </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>Code, in connection with or at which allergens capable of </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>causing anaphylaxis may be present, including, but not limited </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>to, independent contractors who provide student transportation </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>to schools, recreation camps, colleges and universities, day </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>care facilities, youth sports leagues, amusement parks, </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>restaurants, sports arenas, and places of employment. The </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>Department shall, by rule, determine what constitutes a day </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>care facility under this definition.</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"Authorized individual" means an individual who has </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><u><code>successfully completed the training program under Section 10 </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><u><code>of this Act.</code></u><code> </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Department" means the Department of Public Health.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Epinephrine injector" includes an auto-injector approved </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>by the United States Food and Drug Administration for the </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>administration of epinephrine and a pre-filled syringe </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>approved by the United States Food and Drug Administration and </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>used for the administration of epinephrine that contains a </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>pre-measured dose of epinephrine that is equivalent to the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>dosages used in an auto-injector. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Health care practitioner" means a physician licensed to </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>practice medicine in all its branches under the Medical </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>Practice Act of 1987, a physician assistant under the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>Physician Assistant Practice Act of 1987 with prescriptive </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>authority, or an advanced practice registered nurse with </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>prescribing authority under Article 65 of the Nurse Practice </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>Act.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Pharmacist" has the meaning given to that term under </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>subsection (k-5) of Section 3 of the Pharmacy Practice Act.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Undesignated epinephrine injector" means an epinephrine </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>injector prescribed in the name of an authorized entity.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-513, eff. 1-1-18; </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>100-799, eff. 1-1-19</code><code>.)</code><br> </td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 27/10)</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 10. </code><code>Prescription to authorized entity; use; training.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) A health care practitioner may prescribe epinephrine </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>injectors in the name of an authorized entity for use in </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>accordance with this Act, and pharmacists and health care </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>practitioners may dispense epinephrine injectors pursuant to a </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>prescription issued in the name of an authorized entity. Such </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>prescriptions shall be valid for a period of 2 years.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) An authorized entity may acquire and stock a supply of </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>undesignated epinephrine injectors pursuant to a prescription </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>issued under subsection (a) of this Section. Such undesignated </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>epinephrine injectors shall be stored in a location readily </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>accessible in an emergency and in accordance with the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>instructions for use of the epinephrine injectors. The </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>Department may establish any additional requirements an </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>authorized entity must follow under this Act.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) An employee or agent of an authorized entity </code><u><code>who is an </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>authorized individual</code></u><code> or </code><u><code>any other</code></u><code> </code><strike><code>other</code></strike><code> individual who </code><u><code>is an </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>authorized individual</code></u><code> </code><strike><code>has completed training under subsection </code></strike></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><strike><code>(d) of this Section</code></strike><code> may:</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) provide an epinephrine injector to any individual </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>on the property of the authorized entity whom the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>employee, agent, or other individual believes in good </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>faith is experiencing anaphylaxis, or to the parent, </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>guardian, or caregiver of such individual, for immediate </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>administration, regardless of whether the individual has a </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>prescription for an epinephrine injector or has previously </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>been diagnosed with an allergy; or</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) administer an epinephrine injector to any </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>individual on the property of the authorized entity whom </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>the employee, agent, or other individual believes in good </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>faith is experiencing anaphylaxis, regardless of whether </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>the individual has a prescription for an epinephrine </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>injector or has previously been diagnosed with an allergy.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) An employee, agent, or other individual authorized </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>must complete an anaphylaxis training program before he or she </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>is able to provide or administer an epinephrine injector under </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>this Section. Such training shall be valid for a period of 2 </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>years and shall be conducted by a nationally recognized </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>organization experienced in training laypersons in emergency </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>health treatment. The Department shall include links to </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>training providers' websites on its website.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Training shall include, but is not limited to:</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) how to recognize signs and symptoms of an allergic </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>reaction, including anaphylaxis;</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) how to administer an epinephrine injector; and</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) a test demonstrating competency of the knowledge </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>required to recognize anaphylaxis and administer an </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>epinephrine injector.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Training may also include, but is not limited to:</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(A) a review of high-risk areas on the authorized </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>entity's property and its related facilities;</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(B) steps to take to prevent exposure to allergens;</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(C) emergency follow-up procedures; and</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(D) other criteria as determined in rules adopted </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>pursuant to this Act.</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Training may be conducted either online or in person. </code><u><code>The </code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><u><code>entity or individual conducting the training shall issue a </code></u></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><u><code>certificate to each person who successfully completes the </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>anaphylaxis training program.</code></u><code> The Department shall approve </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>training programs and list permitted training programs on the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Department's Internet website.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19</code><code>.)</code><br> </td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 27/25 new)</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>Sec. 25. </code></u><u><code>Good Samaritan protections. </code></u><u><code>Any act or omission </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><u><code>taken in good faith pursuant to this Act by any of the </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>following entities or individuals shall be considered </code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><u><code>emergency care, advice, or assistance under the Good Samaritan </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>Act: (i) an authorized entity that possesses and makes </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>available epinephrine injectors and its employees or agents; </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>(ii) an authorized individual who possesses, makes available, </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><u><code>and administers epinephrine injectors; (iii) a pharmacy or </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><u><code>manufacturer that dispenses epinephrine injectors to an </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><u><code>authorized entity or authorized individual; or (iv) an </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><u><code>individual or entity that conducts the training described in </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>subsection (d) of Section 10 of this Act.</code></u><br> </td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 10. </code><code>The Good Samaritan Act is amended by adding </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>Section 66 as follows:</code><br> </td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(745 ILCS 49/66 new)</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>Sec. 66. </code></u><u><code>Provision and administration of epinephrine </code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB2462</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB104 08649 BDA 18702 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><u><code>injectors. </code></u><u><code>Any person meeting the definition of "authorized </code></u></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><u><code>individual" under the Epinephrine Injector Act who acts in </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>good faith to provide or administer epinephrine injectors </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><u><code>pursuant to that Act, shall not, as a result of his or her acts </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>or omissions, except willful and wanton misconduct on the part </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>of that person, be liable to a person to whom such epinephrine </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><u><code>injector is given to or administered for civil damages.</code></u></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
